BRIEF published on 10/21/2025 at 18:35, 5 months 23 days ago Theraclion obtains crucial certification in China Medical Theraclion SONOVEIN® Focused Ultrasound Chinese Certification
BRIEF published on 10/21/2025 at 18:35, 5 months 23 days ago Theraclion obtient une certification cruciale en Chine Medical Theraclion SONOVEIN® Ultrasons Focalisés Certification Chinoise
PRESS RELEASE published on 10/21/2025 at 18:30, 5 months 23 days ago Informations privilégiées / Autres communiqués Theraclion obtient une certification chinoise majeure pour son dispositif Sonovein® et progresse vers l'accès au marché en Chine, renforçant ainsi sa position dans le secteur des technologies médicales avancées Marché Chinois Technologies Médicales Theraclion SONOVEIN® Certification Chinoise
BRIEF published on 10/10/2025 at 18:35, 6 months 3 days ago Monthly publication of Theraclion voting rights Share Capital Voting Rights Investment Euronext Growth Theraclion
BRIEF published on 10/10/2025 at 18:35, 6 months 3 days ago Publication mensuelle des droits de vote de Theraclion Investissement Droits De Vote Capital Social Euronext Growth Theraclion
PRESS RELEASE published on 10/10/2025 at 18:30, 6 months 3 days ago Inside Information / Other news releases Theraclion provides monthly update on total voting rights and shares. The French MedTech company uses focused ultrasound for non-invasive treatment. CE-marked platform SONOVEIN® targets varicose veins Voting Rights Shares Theraclion SONOVEIN Focused Ultrasound
PRESS RELEASE published on 10/10/2025 at 18:30, 6 months 3 days ago Informations privilégiées / Autres communiqués Communiqué mensuel sur les droits de vote et actions de Theraclion, société française de MedTech. Détails des actions en circulation et droits de vote réels Euronext PEA PME MedTech France Theraclion
BRIEF published on 09/15/2025 at 18:35, 6 months 28 days ago Theraclion Réussit son Étude Pivotal avec un Taux d'Occlusion de 96,8 % FDA Essai Clinique Theraclion SONOVEIN® Varices
BRIEF published on 09/15/2025 at 18:35, 6 months 28 days ago Theraclion Successfully Completes Pivotal Study with 96.8% Occlusion Rate FDA Clinical Trial Theraclion SONOVEIN® Varicose Veins
PRESS RELEASE published on 09/15/2025 at 18:30, 6 months 28 days ago Informations privilégiées / Autres communiqués Theraclion annonce le succès de son étude pivotale américaine FDA avec un taux d'occlusion de 96,8% pour Sonovein®, sa plateforme de traitement des varices par ultrasons focalisés de haute intensité FDA Theraclion SONOVEIN Étude Pivotale Occlusion
Published on 04/14/2026 at 14:00, 16 minutes ago GameSquare Expands Share Repurchase Authorization to $15 Million
Published on 04/14/2026 at 14:00, 16 minutes ago Revolve Announces Change to Board of Directors and Provides Corporate Update
Published on 04/14/2026 at 13:30, 46 minutes ago Nextech3D.ai Achieves Cash Flow Positive Operations After AI‑Enabled Optimization; Blockchain Ticketing With Fiat Checkout Ready
Published on 04/14/2026 at 13:15, 1 hour 1 minute ago Bayhorse Silver Announces Brokered LIFE Offering for Gross Proceeds of up to C$4.0 Million
Published on 04/14/2026 at 13:05, 1 hour 11 minutes ago Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Published on 04/14/2026 at 14:00, 16 minutes ago Mutares has sold all subsidiaries of inTime Group to Tawin Holdings Group
Published on 04/14/2026 at 13:20, 55 minutes ago Annual Shareholder Meeting of Comet Holding AG approves all agenda items
Published on 04/14/2026 at 13:19, 56 minutes ago EQS-Adhoc: EPH Group AG: EPH Group AG initiates a cash capital increase while preserving subscription rights with an issue volume of up to approximately EUR 10.3 million.
Published on 04/14/2026 at 13:04, 1 hour 11 minutes ago Aroundtown announces successful result of the voluntary Exchange Offer for GCP shares, increasing its holding in GCP to 81.5%
Published on 04/14/2026 at 08:30, 5 hours 46 minutes ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 19 hours 1 minute ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 20 hours 1 minute ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
Published on 04/13/2026 at 18:15, 20 hours 1 minute ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2026
Published on 04/13/2026 at 18:09, 20 hours 6 minutes ago Infotel : Cessation et mise en œuvre d’un nouveau contrat de liquidité avec Invest Securities.
